Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valproate-induced hyperammonemic encephalopathy.

N Segura-Bruna1, A Rodriguez-Campello, V Puente

  • 1Servei de Neurologia, Hospital del Mar, Barcelona, Spain. 94407@imas.imim.es

Acta Neurologica Scandinavica
|June 16, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Corrigendum to "Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study" [Park. Relat. Disord. (2024) 106993].

Parkinsonism & related disorders·2024
Same author

Pilot therapeutic education program in multiple system atrophy: Safety, quality of life and satisfaction from a national registry based longitudinal study.

Parkinsonism & related disorders·2024
Same author

[Clinical profile and non-recreational methamphetamine abuse (shabu) among stroke patients in the Philippine population].

Revista de neurologia·2023
Same author

Lipidomic signature of stroke recurrence after transient ischemic attack.

Scientific reports·2023
Same author

The CORCOBIA study: Cut-off points of Alzheimer's disease CSF biomarkers in a clinical cohort.

Neurologia·2022
Same author

Migraine-Associated Common Genetic Variants Confer Greater Risk of Posterior vs. Anterior Circulation Ischemic Stroke☆.

Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association·2022
Same journal

Editorial.

Acta neurologica Scandinavica·2022
Same journal

Advances in sudden unexpected death in epilepsy.

Acta neurologica Scandinavica·2022
Same journal

Non-convulsive seizures and non-convulsive status epilepticus in neuro-intensive care unit.

Acta neurologica Scandinavica·2022
Same journal

Positron emission tomography in autoimmune encephalitis: Clinical implications and future directions.

Acta neurologica Scandinavica·2022
Same journal

Seizure detection based on wearable devices: A review of device, mechanism, and algorithm.

Acta neurologica Scandinavica·2022
Same journal

Walking confidence and perceived locomotion ability explain participation after stroke: A cross-sectional experimental study.

Acta neurologica Scandinavica·2022
See all related articles

Valproate-induced hyperammonemic encephalopathy (VHE) is a rare complication of valproate (VPA) treatment. Early screening for hyperammonemia and potential carnitine deficiency is crucial for prompt diagnosis and management.

Area of Science:

  • Neurology
  • Biochemistry
  • Pharmacology

Background:

  • Valproate-induced hyperammonemic encephalopathy (VHE) is an uncommon but serious complication of valproate (VPA) therapy.
  • VHE presents with neurological symptoms including altered consciousness, cognitive deficits, and lethargy.
  • The exact cause of VHE is not fully understood, but hyperammonemia is considered the primary driver of the clinical syndrome.

Purpose of the Study:

  • To review predisposing factors, screening methods, and biochemical mechanisms of VHE.
  • To discuss current and emerging treatments for VHE.
  • To highlight the importance of early diagnosis and intervention in VHE.

Main Methods:

  • Comprehensive literature review of VHE.
  • Analysis of biochemical pathways, including urea cycle inhibition.

Related Experiment Videos

  • Examination of clinical presentations, diagnostic tools (e.g., EEG, blood ammonium levels), and treatment strategies.

    • Main Results:

    • Hyperammonemia in VHE may result from carbamoylphosphate synthetase-I inhibition, potentially exacerbated by polytherapy.
    • Increased brain glutamine levels due to hyperammonemia can lead to cerebral edema.
    • Carnitine supplementation may offer a favorable clinical response, possibly due to VPA-induced carnitine deficiency.

    Conclusions:

    • VHE necessitates ruling out urea cycle enzyme deficiencies and monitoring blood ammonium levels.
    • Electroencephalography (EEG) shows characteristic signs of severe encephalopathy.
    • Discontinuation of VPA typically leads to normalization of clinical and biochemical findings.